LONDON - Maxim Pharmaceuticals Inc. became the first to make an all-electronic submission in Europe last week, when it filed for Ceplene in combination with interleukin-2 for the treatment of advanced malignant melanoma. (BioWorld International)
LONDON - Astex Technology Ltd. raised £23 million (US$38.9 million) through its acquisition of German genomics company MetaGen Pharmaceuticals GmbH with its £15 million cash, and by raising £8 million from existing investors. (BioWorld International)
LONDON - Astex Technology Ltd. raised £23 million (US$38.9 million) through its acquisition of German genomics company MetaGen Pharmaceuticals GmbH with its £15 million cash, and by raising £8 million from existing investors. (BioWorld International)
LONDON - Alizyme plc raised £11.5 million (US$19.5 million) in a placing of 6.8 million shares, giving it financial headroom as it negotiates deals for its three Phase III products, and allowing it to expand the commercial potential of its anti-obesity drug, ATL-962, by funding an additional Phase II trial in Type II diabetes. (BioWorld International)
LONDON - Alizyme plc raised £11.5 million (US$19.5 million) in a placing of 6.8 million shares, giving it financial headroom as it negotiates deals for its three Phase III products, and allowing it to expand the commercial potential of its anti-obesity drug, ATL-962, by funding an additional Phase II trial in Type II diabetes. (BioWorld International)
LONDON - The prospects of lifting the moratorium on genetically modified crops in Europe were undermined severely when the results of the biggest GM crop trials anywhere in the world concluded that herbicide-tolerant oil seed rape and sugar beet are more harmful to wildlife than conventional crops. (BioWorld International)
